| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $452.9M | +11.7% |
| Cost of Revenue | $1.8M | +7.5% |
| R&D Expense | $13.7M | +13.2% |
| SG&A Expense | $86.8M | +20.8% |
| Operating Income | -$29.1M | +71.7% |
| Interest Expense | $11.0M | +43.9% |
| Pre-tax Income | -$30.6M | +71.2% |
| Income Tax | -$2.4M | +86.5% |
| Net Income | -$28.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.7M | -19.9% |
| Accounts Receivable | $4.0M | +51.7% |
| Current Assets | $382.4M | -4.7% |
| Total Assets | $1.11B | +0.1% |
| Current Liabilities | $78.5M | +29.7% |
| Long-term Debt | $67.8M | +2.5% |
| Total Liabilities | $209.3M | +5.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +75.1% |
| Capital Expenditures | $2.1M | +874.8% |
| Investing Cash Flow | -$15.9M | -161.5% |
| Financing Cash Flow | -$6.2M | -109.7% |
| Free Cash Flow | -$8.8M | +67.6% |
| +68.2% |
| EPS (Basic) | -$2.37 | +45.6% |
| EPS (Diluted) | -$2.37 | +45.6% |
| Stockholders' Equity |
| $606.0M |
| -6.9% |